Profile data is unavailable for this security.
About the company
TAKE Solutions Limited is an India-based company, which provides domain-intensive services as a full-service clinical research organization (CRO) supporting pharma, biotech, and devices companies across the world. The Company operates through two segments: Life Sciences and Supply Chain Management. It offers full-service clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. Its services spans from clinical trials to regulatory submissions to post-marketing safety. It provides services in life sciences sector across the spectrum of clinical, regulatory, safety and pharmacovigilance, networks, and consulting to deliver end-to-end solutions and services across processes, technology, and analytics to both domestic and global clients. It also provides information technology (IT) infrastructure and support, engineering, designing, and sourcing services. The Company operates in North America, Europe, Asia, and South America.
- Revenue in INR (TTM)850.73m
- Net income in INR-113.89m
- Incorporated2000
- Employees211.00
- LocationTake Solutions LtdNo27Tank Bund Road, Nungambakkam, ChennaiCHENNAI 600034IndiaIND
- Phone+91 4 466110700
- Fax+91 4 445909009
- Websitehttps://www.takesolutions.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brooks Laboratories Ltd | 744.61m | -142.85m | 2.64bn | 296.00 | -- | -- | -- | 3.55 | -5.65 | -5.65 | 29.38 | -- | -- | -- | -- | 2,515,585.00 | -- | -12.10 | -- | -19.53 | 30.02 | 26.63 | -19.18 | -28.01 | -- | 0.0672 | -- | -- | -30.69 | 2.12 | -85.13 | -- | -39.43 | -- |
| Take Solutions Ltd | 850.73m | -113.89m | 3.31bn | 211.00 | -- | -- | -- | 3.89 | -0.7833 | -4.44 | 5.90 | -- | -- | -- | -- | 4,031,915.00 | -- | -4.65 | -- | -7.25 | 55.38 | 71.04 | -13.49 | -7.07 | -- | 1.07 | -- | -- | -71.03 | -34.66 | 43.41 | -- | -44.31 | -- |
| Par Drugs and Chemicals Ltd | 973.13m | 142.29m | 3.50bn | 105.00 | 24.61 | -- | 19.87 | 3.60 | 11.56 | 11.56 | 79.09 | -- | -- | -- | -- | 9,267,876.00 | -- | 11.67 | -- | 14.69 | 63.65 | 43.30 | 14.62 | 11.82 | -- | 210.51 | -- | -- | 27.54 | 17.71 | 23.02 | 49.94 | 64.23 | -- |
| Medico Remedies Ltd | 1.32bn | 69.58m | 3.88bn | -- | 56.21 | -- | 39.53 | 2.95 | 0.8326 | 0.8326 | 15.75 | -- | -- | -- | -- | -- | -- | 4.76 | -- | 10.00 | 24.15 | 24.40 | 5.29 | 3.14 | -- | 11.07 | -- | -- | 16.04 | 18.14 | 48.09 | 42.78 | 52.68 | -- |
| Lyka Labs Ltd | 1.06bn | -35.60m | 4.26bn | 713.00 | -- | -- | 43.31 | 4.03 | -1.23 | -1.23 | 33.69 | -- | -- | -- | -- | -- | -- | -5.48 | -- | -9.31 | 61.37 | 59.75 | -3.34 | -10.63 | -- | 0.5422 | -- | -- | -52.05 | 8.95 | -133.88 | -- | 17.78 | -- |
